{
    "clinical_study": {
        "@rank": "18245", 
        "arm_group": {
            "arm_group_label": "alcohol doses", 
            "arm_group_type": "Placebo Comparator"
        }, 
        "brief_summary": {
            "textblock": "There are mixed reports on nicotine's effects on ethanol-induced impairment in cognitive\n      performance and behavior in humans. The main objective of this study is to characterize the\n      interactive effects of acute intravenous (IV) ethanol and nicotine administration on\n      cognition and behavior in healthy smokers. The general hypothesis is that nicotine will\n      attenuate the negative effects of ethanol on cognition and subjective stimulant/sedative\n      effects of ethanol."
        }, 
        "brief_title": "Interactive Effects of IV Ethanol and IV Nicotine", 
        "completion_date": {
            "#text": "August 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Healthy", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Male and female;\n\n          2. between the ages of 21 and 50 years;\n\n          3. medically and neurologically healthy on the basis of history, physical examination,\n             EKG, screening laboratories\n\n          4. history of smoking daily for the past 12 months, at least 5 cigarettes daily; not\n             seeking treatment for nicotine dependence\n\n          5. social drinkers  no maximum level of alcohol consumption will be defined a priori but\n             individuals who met current DSM -IV criteria for alcohol dependence (abuse will be\n             allowed) will be excluded from the study.\n\n        Exclusion Criteria:\n\n          1. history of major medical illnesses that the physician investigator deems as\n             contraindicated for the patient to be in the study;\n\n          2. regular use of psychotropic medication (antidepressants, antipsychotics, or\n             anxiolytics) and recent psychiatric diagnosis and treatment for Axis I disorders\n             including major depression, bipolar affective disorder, schizophrenia or panic\n             disorder;\n\n          3. current abuse of any recreational or prescription drugs (except alcohol);\n\n          4. alcohol na\u00efve."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "50 Years", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 18, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01814410", 
            "org_study_id": "ER0006"
        }, 
        "intervention": [
            {
                "arm_group_label": "alcohol doses", 
                "intervention_name": "Intravenous Ethanol", 
                "intervention_type": "Drug", 
                "other_name": "Alcohol"
            }, 
            {
                "arm_group_label": "alcohol doses", 
                "intervention_name": "Intravenous Nicotine", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "alcohol doses", 
                "intervention_name": "Intravenous Placebo", 
                "intervention_type": "Drug", 
                "other_name": "Saline Solution"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Ethanol", 
                "Nicotine polacrilex", 
                "Nicotine"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Intravenous Ethanol", 
            "Intravenous Nicotine", 
            "Interactive effects", 
            "cognition", 
            "subjective effects", 
            "healthy subjects"
        ], 
        "lastchanged_date": "January 14, 2014", 
        "location": {
            "contact": {
                "last_name": "Elizabeth Ralevski, Ph.D."
            }, 
            "facility": {
                "address": {
                    "city": "West Haven", 
                    "country": "United States", 
                    "state": "Connecticut", 
                    "zip": "06516"
                }, 
                "name": "West Haven VA Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Laboratory Study on the Interactive Effects of IV Ethanol and IV Nicotine on Subjective Effects and Cognition", 
        "overall_contact": {
            "email": "elizabeth.ralevski@yale.edu", 
            "last_name": "Elizabeth Ralevski, Ph.D.", 
            "phone": "203-932-5711", 
            "phone_ext": "4282"
        }, 
        "overall_contact_backup": {
            "email": "diana.limoncelli@yale.edu", 
            "last_name": "Diana Limoncelli, BA", 
            "phone": "203-932-5711", 
            "phone_ext": "5217"
        }, 
        "overall_official": {
            "affiliation": "Yale University", 
            "last_name": "Elizabeth Ralevski, Ph.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Food and Drug Administration", 
                "United States: Institutional Review Board"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "A 14-item scale with 7 items designed to assess stimulant effects associated with the ascending limb of ethanol intoxication and 7 items developed to measure sedative effects associated with the descending limb of ethanol intoxication.", 
            "measure": "Biphasic Alcohol Effects Scale (BAES)", 
            "safety_issue": "No", 
            "time_frame": "2 minutes"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01814410"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Yale University", 
            "investigator_full_name": "Elizabeth Ralevski", 
            "investigator_title": "Assistant Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "The following items will be assessed: high, depressed, anxious, drowsy, irritable, tired, sad, angry, nervous, nauseous, blurred vision, flushed, headache, lightheaded, dizzy, sweating, abdominal discomfort and tingling .", 
                "measure": "Visual Analog Scales of Mood States", 
                "safety_issue": "No", 
                "time_frame": "1 minute"
            }, 
            {
                "description": "A measure of smoking urges reflecting not only intent and desire to smoke, and anticipation of pleasure from smoking, but also anticipation of relief from negative affect and nicotine withdrawal, and urgent and overwhelming desire to smoke.", 
                "measure": "QSU-Brief", 
                "safety_issue": "No", 
                "time_frame": "2 minutes"
            }, 
            {
                "description": "A test of psychomotor performance, which measures motor persistence, sustained attention, response speed and visuomotor coordination.", 
                "measure": "Digit Symbol Substitution Task", 
                "safety_issue": "No", 
                "time_frame": "2 minutes"
            }
        ], 
        "source": "Yale University", 
        "sponsors": {
            "collaborator": {
                "agency": "South Central VA Mental Illness Research, Education & Clinical Center", 
                "agency_class": "U.S. Fed"
            }, 
            "lead_sponsor": {
                "agency": "Yale University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Single Blind (Subject), Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}